Aug 30, 2023

Key Players KD Pharma Group, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Omega Protein Corporation, Croda International PLC, Novotech Nutraceuticals, Polaris SA, and AlgalR NutraPharms Pvt. Ltd Immediate Delivery Available, Buy Now @  https://www.consegicbusinessintelligence.com/secure-checkout/1201 Global EPA and DHA Market Segmentation Details: Based on Type, the eicosapentaenoic acid (EPA) segment contributed the largest shares to the market growth in 2022. Docosahexaenoic acid (DHA) is important for the growth and efficient functional development of the brain in infants. Additionally, DHA is required for regular maintenance the normal brain function in adults. Hence, the inclusion of plentiful DHA in the diet enhances learning ability. Docosahexaenoic acid (DHA) is an ideal solution for applications such as dietary supplements, food & beverage, and others. Thus, due to the above benefits, the adoption of docosahexaenoic acid (DHA) is increasing in the above applications, which, in turn, is driving segment growth. Based on Source, the fish oil segment accounted for the largest market share in the year 2022. Fish oil has a higher level of protein, superior magnesium level, significant content of selenium, vitamin B12, and higher potassium, among others. These vital nutrients ensure a superior level of EPA and DHA content in fish oil. Fish oils such as mackerel, salmon, seabass, oysters, sardines, shrimp, and others are superior sources of EPA and DHA. The development of new DHA products sourced from fish oil is increasing. Hence, the aforementioned nutrient properties associated with fish oil are boosting market growth. Based on Application, the dietary supplements segment accounted for the largest market share in the year 2022. EPA and DHA are deployed in dietary supplements to ensure superior health benefits such as significant brain and eye development of fetuses and infants. Furthermore, the deployment of EPA and DHA in dietary supplements ensures a reduction in heart disease risks, reduces the risk of early preterm births, and others. Henceforth, the above benefits are leading to the increasing utilization of EPA and DHA in dietary supplements, thereby amplifying market growth. Based on Region, in the year 2022, Asia Pacific accounted for the largest share contribution to the market growth, owing to the growth of the pharmaceuticals industry. For instance, according to India Brand Equity Foundation (IBEF), in the year 2020, the pharmaceuticals market in India was valued at USD 42.0 billion, and by the year 2024, it is projected at USD 65.0 billion, an increase of 54.8%. Therefore, the advancement in the pharmaceutical industry is spurring the revenue growth of the EPA and DHA market. Competitive Landscape KD Pharma Group, Corbion NV, Novasep Holding SAS, and Neptune Wellness Solutions are major market players that comprise the latest market circumstances. These companies are substantially leveraging their technologies for the development of a new range of EPA and DHA. Further, the EPA and DHA market is expected to grow steadily due to rising demand from pharmaceuticals, especially in the regions such as the Asia Pacific, the Middle East, and Europe are estimated to boost the market statistics in the coming years. Additionally, the trend toward the development of new food and beverage manufacturing facilities is expected to increase the competition in the market. Recent Developments In February 2023, Grøntvedt Biotech, headquartered in Norway launched CETO3 for its cetoleic acid and omega-3 ingredient. Cetoleic acid is ideal for application for the manufacturing of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Hence, the recent development of products is accelerating the market growth. Key Market Takeaways Asia Pacific accounted for the highest market share at 38.12% and was valued at USD 636.62 million in 2022 and is expected to reach USD 1,033.57 million in 2030. Moreover, in Asia Pacific, China accounted for the highest market share of 22.50% during the base year of 2022. Based on grade, the eicosapentaenoic acid (EPA) segment accounted for the highest share contribution to the EPA and DHA market statistics in 2022. In the context of source, the fish oil segment is expected to contribute significant shares to the growth of EPA and DHA market statistics during the forecast period. On the basis of application, the dietary supplements segment accounted for the highest share contribution to the EPA and DHA market size in 2022. North America is expected to boost the market demand for EPA and DHAs due to the increasing investments in new pharmaceutical manufacturing plants in countries such as the United States and Canada. Browse Full Report & TOC @  https://www.consegicbusinessintelligence.com/epa-and-dha-market List of Major Global EPA and DHA Market: KD Pharma Group By Type What was the market size of the EPA and DHA industry in 2022? In 2022, the market size of EPA and DHA was USD 1,670.04 million. What will be the potential market valuation for the EPA and DHA industry by 2030? In 2030, the market size of EPA and DHA will be expected to reach USD 2,680.43 million. What are the key factors driving the growth of the EPA and DHA market? Increasing demand for dietary supplements is benefiting the growth of the global EPA and DHA market. What is the dominating segment in the EPA and DHA market by source? In 2022, the fish oil segment accounted for the highest market share of 39.30% in the overall EPA and DHA market. Based on current market trends and future predictions, which geographical region is the dominating region in the EPA and DHA market? Asia Pacific accounted for the highest market share in the overall EPA and DHA market. Our Other Research Reports here:-